Search Results - "Tatsumi, Koichiro"

Vascular remodeling in pulmonary arterial hypertension: Multiple cancer-like pathways and possible treatment modalities by Sakao, Seiichiro, Tatsumi, Koichiro

“…Abstract Most patients with severe pulmonary arterial hypertension (PAH) demonstrate persistent structural alterations in small pulmonary arterioles at the…”
Get full text

Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation by Sakao, Seiichiro, Tatsumi, Koichiro, Voelkel, Norbert F

“…Severe pulmonary arterial hypertension, whether idiopathic or secondary, is characterized by structural alterations of microscopically small pulmonary…”
Get full text

Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition by Suzuki, Toshio, Tada, Yuji, Gladson, Santhi, Nishimura, Rintaro, Shimomura, Iwao, Karasawa, Satoshi, Tatsumi, Koichiro, West, James

“…Pulmonary fibrosis is a late manifestation of acute respiratory distress syndrome (ARDS). Sepsis is a major cause of ARDS, and its pathogenesis includes…”
Get full text

Reference values for spirometry, including vital capacity, in Japanese adults calculated with the LMS method and compared with previous values by Kubota, Masaru, M.D., Ph.D, Kobayashi, Hirosuke, M.D., Ph.D, Quanjer, Philip H., M.D., Ph.D, Omori, Hisamitsu, M.D., Ph.D, Tatsumi, Koichiro, M.D., Ph.D, Kanazawa, Minoru, M.D., Ph.D

“…Abstract Background Reference values for lung function tests should be periodically updated because of birth cohort effects and improved technology. This study…”
Get full text

Effectiveness and Outcome of Pulmonary Arterial Hypertension-Specific Therapy in Japanese Patients With Pulmonary Arterial Hypertension by Tamura, Yuichi, Kumamaru, Hiraku, Satoh, Toru, Miyata, Hiroaki, Ogawa, Aiko, Tanabe, Nobuhiro, Hatano, Masaru, Yao, Atsushi, Abe, Kohtaro, Tsujino, Ichizo, Fukuda, Keiichi, Kimura, Hiroshi, Kuwana, Masataka, Matsubara, Hiromi, Tatsumi, Koichiro, on behalf of the Japan PH Registry (JAPHR) Network

“…Background:The trend of the initial treatment strategy for pulmonary arterial hypertension (PAH) has changed from monotherapies to upfront combination…”
Get full text

Pathophysiological Roles of Stress-Activated Protein Kinases in Pulmonary Fibrosis by Kasuya, Yoshitoshi, Kim, Jun-Dal, Hatano, Masahiko, Tatsumi, Koichiro, Matsuda, Shuichi

“…Idiopathic pulmonary fibrosis (IPF) is one of the most symptomatic progressive fibrotic lung diseases, in which patients have an extremely poor prognosis…”
Get full text

Isolation and characterization of endothelial-to-mesenchymal transition cells in pulmonary arterial hypertension by Suzuki, Toshio, Carrier, Erica J, Talati, Megha H, Rathinasabapathy, Anandharajan, Chen, Xinping, Nishimura, Rintaro, Tada, Yuji, Tatsumi, Koichiro, West, James

“…Endothelial-to-mesenchymal transition (EndMT) is a process in which endothelial cells lose polarity and cell-to cell contacts, and undergo a dramatic…”
Get more information

Clinical characteristics of pulmonary nocardiosis in immunocompetent patients by Fujita, Tetsuo, Ikari, Jun, Watanabe, Akira, Tatsumi, Koichiro

“…Abstract Pulmonary nocardiosis is a rare but potentially serious infection typically in immunosuppressed patients (ISPs). It is also known to occur in…”
Get full text

Inhaled GM-CSF for Pulmonary Alveolar Proteinosis by Tazawa, Ryushi, Ueda, Takahiro, Abe, Mitsuhiro, Tatsumi, Koichiro, Eda, Ryosuke, Kondoh, Shotaro, Morimoto, Konosuke, Tanaka, Takeshi, Yamaguchi, Etsuro, Takahashi, Ayumu, Oda, Miku, Ishii, Haruyuki, Izumi, Shinyu, Sugiyama, Haruhito, Nakagawa, Atsushi, Tomii, Keisuke, Suzuki, Masaru, Konno, Satoshi, Ohkouchi, Shinya, Tode, Naoki, Handa, Tomohiro, Hirai, Toyohiro, Inoue, Yoshikazu, Arai, Toru, Asakawa, Katsuaki, Sakagami, Takuro, Hashimoto, Atsushi, Tanaka, Takahiro, Takada, Toshinori, Mikami, Ayako, Kitamura, Nobutaka, Nakata, Koh

“…In patients with autoimmune pulmonary alveolar proteinosis, the use of inhaled recombinant granulocyte–macrophage colony-stimulating factor resulted in a…”
Get full text

Selexipag for the treatment of chronic thromboembolic pulmonary hypertension by Ogo, Takeshi, Shimokawahara, Hiroto, Kinoshita, Hideyuki, Sakao, Seiichiro, Abe, Kohtaro, Matoba, Satoaki, Motoki, Hirohiko, Takama, Noriaki, Ako, Junya, Ikeda, Yasuhiro, Joho, Shuji, Maki, Hisataka, Saeki, Takahiro, Sugano, Teruyasu, Tsujino, Ichizo, Yoshioka, Koichiro, Shiota, Naoki, Tanaka, Shinichi, Yamamoto, Chieko, Tanabe, Nobuhiro, Tatsumi, Koichiro

“…Background Treatment options for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) remain limited. Selexipag, an oral selective IP prostacyclin…”
Get full text

Endobronchial Ultrasonography for Positron Emission Tomography and Computed Tomography–Negative Lymph Node Staging in Non-Small Cell Lung Cancer by Shingyoji, Masato, MD, PhD, Nakajima, Takahiro, MD, PhD, Yoshino, Mitsuru, MD, PhD, Yoshida, Yasushi, MD, PhD, Ashinuma, Hironori, MD, PhD, Itakura, Meiji, MD, PhD, Tatsumi, Koichiro, MD, PhD, Iizasa, Toshihiko, MD, PhD

“…Background Integrated positron emission tomography (PET) with computed tomography (CT) is a useful modality to investigate lymph node metastases for non-small…”
Get full text

Different Transcriptome Features of Peripheral Blood Mononuclear Cells in Non-Emphysematous Chronic Obstructive Pulmonary Disease by Imamoto, Takuro, Kawasaki, Takeshi, Sato, Hironori, Tatsumi, Koichiro, Ishii, Daisuke, Yoshioka, Keiichiro, Hasegawa, Yoshinori, Ohara, Osamu, Suzuki, Takuji

“…Non-emphysematous chronic obstructive pulmonary disease (COPD), which is defined based on chest computed tomography findings, presented different transcriptome…”
Get full text

Effects of Anti-Fibrotic Drugs on Transcriptome of Peripheral Blood Mononuclear Cells in Idiopathic Pulmonary Fibrosis by Ishii, Daisuke, Kawasaki, Takeshi, Sato, Hironori, Tatsumi, Koichiro, Imamoto, Takuro, Yoshioka, Keiichiro, Abe, Mitsuhiro, Hasegawa, Yoshinori, Ohara, Osamu, Suzuki, Takuji

“…Two anti-fibrotic drugs, pirfenidone (PFD) and nintedanib (NTD), are currently used to treat idiopathic pulmonary fibrosis (IPF). Peripheral blood mononuclear…”
Get full text

Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer by Ohashi, Kana, Nishito, Yukari, Fukuda, Hironori, Sadahiro, Ryoichi, Yoshida, Yukihiro, Watanabe, Shun-ichi, Motoi, Noriko, Sonobe, Yukiko, Mizuno, Hideaki, Tsunoda, Hiroyuki, Tatsumi, Koichiro, Suzuki, Takuji, Ochiai, Atsushi, Aoki, Kazunori

“…Inflammatory factors in the peripheral blood, such as the C-reactive protein level and neutrophil-to-lymphocyte ratio (NLR), are prognostic markers in multiple…”
Get full text

Risk factors for skeletal-related events in non-small cell lung cancer patients treated with bone-modifying agents by Saito, Go, Ebata, Takahiro, Ishiwata, Tsukasa, Iwasawa, Shunichiro, Yoshino, Ichiro, Takiguchi, Yuichi, Tatsumi, Koichiro

“…Purpose The risk factors for skeletal-related events (SREs) among non-small cell lung cancer (NSCLC) patients during treatment with bone-modifying agents…”
Get full text

Long-Term Outcome of Chronic Thromboembolic Pulmonary Hypertension at a Single Japanese Pulmonary Endarterectomy Center by Miwa, Hideki, Tanabe, Nobuhiro, Jujo, Takayuki, Kato, Fumiaki, Anazawa, Rie, Yamamoto, Keiko, Naito, Akira, Kasai, Hajime, Nishimura, Rintaro, Suda, Rika, Sugiura, Toshihiko, Sakao, Seiichiro, Ishida, Keiichi, Masuda, Masahisa, Tatsumi, Koichiro

“…Background:Several new treatments for chronic thromboembolic pulmonary hypertension (CTEPH) have appeared in recent years, which have led to changes in the…”
Get full text

Recent progress in the diagnosis and management of chronic thromboembolic pulmonary hypertension by Tanabe, Nobuhiro, Sugiura, Toshihiko, Tatsumi, Koichiro

“…Abstract Chronic thromboembolic pulmonary hypertension (CTEPH) is a form of pulmonary hypertension caused by non-resolving thromboembolisms of the pulmonary…”
Get full text

Hypoxic Pulmonary Vasoconstriction and the Diffusing Capacity in Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis by Sakao, Seiichiro, Tanabe, Nobuhiro, Tatsumi, Koichiro

Get full text

Long-term outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension by Ishida, Keiichi, MD, PhD, Masuda, Masahisa, MD, PhD, Tanabe, Nobuhiro, MD, PhD, Matsumiya, Goro, MD, PhD, Tatsumi, Koichiro, MD, PhD, Nakajima, Nobuyuki, MD, PhD

“…Objectives Pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension. Although several reports demonstrated…”
Get full text

Endothelial cell-related autophagic pathways in Sugen/hypoxia-exposed pulmonary arterial hypertensive rats by Kato, Fumiaki, Sakao, Seiichiro, Takeuchi, Takao, Suzuki, Toshio, Nishimura, Rintaro, Yasuda, Tadashi, Tanabe, Nobuhiro, Tatsumi, Koichiro

“…Pulmonary arterial hypertension (PAH) is characterized by progressive obstructive remodeling of pulmonary arteries. However, no reports have described the…”
Get more information